Related Articles
Validation of a popular consumer-grade cuffless blood pressure device for continuous 24-hour monitoring
AbstractBackground. Hypertension is a leading cause of death worldwide, yet many hypertensive cases remain undiagnosed. Wearable, cuffless blood pressure m
An overview of gene therapy approaches in SCD & thalassemia: gene addition versus genome editing
In this video, Maria Domenica Cappellini, MD, University of Milan, Milan, Italy, shares insights into the current state of gene therapy for thalassemia and sickle…
I have a side gig as a data worker training AI and mystery shopping
Brook Hansen, 46, has picked up freelance jobs as a data worker for nearly two decades. The mom of young kids has worked training chatbots,…
ERS Leadership Elections 2025: meet the candidates for Advocacy Council Chair
Last month, voting opened for the ERS Leadership Elections 2025, which presents candidates for ERS Vice President, Advocacy Council Chair, Education Council Chair, and Publications…
The Deadwether Society
Quoth the Financial Times’ How a little-known French literary critic became a bellwether for the US right: René Girard is best known for his theory…
VA Secretary says he’s bullish on continued Oracle Health EHR rollout
Pressed by lawmakers about changes underway at the agency, Veterans Affairs Secretary Doug Collins said the VA is addressing bureaucracy that has stymied the electronic…
Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma
The Lancet Haematology in conversation with · Episode
BBC to use AI to handle viewers’ complaints in £40m Serco contract
The BBC will start using artificial intelligence to handle complaints from viewers and listeners as part of a £40 million deal with Serco, an outsourcing…
Trump’s strange obsession of appointing the wrong people in the realm of healthcare – Part 4
Donald Trump has recently made a range of nominations/appointments in the US health sector. They will influence conventional and so-called alternative medicine (SCAM) in the…
Novartis to keep making malaria drugs if orders dry up amid aid cuts
Swiss drugmaker Novartis will keep making medicines for malaria and leprosy, even if it does not get orders as normal amid the global health funding…
